Search

Your search keyword '"Daisuke Koya"' showing total 444 results

Search Constraints

Start Over You searched for: Author "Daisuke Koya" Remove constraint Author: "Daisuke Koya"
444 results on '"Daisuke Koya"'

Search Results

51. Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study

52. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice

53. CD‐1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis

54. Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)

55. Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches

56. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats

57. Endothelial autophagy deficiency induces IL6 - dependent endothelial mesenchymal transition and organ fibrosis

58. Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats

59. Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort

60. Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity

61. Autophagy in metabolic disease and ageing

62. Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 inhibitors with those receiving dipeptidyl peptidase‐4 inhibitors, using a supervised machine‐learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database

63. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014

64. The impact of dietary protein intake on longevity and metabolic health

65. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice

66. βklotho is essential for the anti‐endothelial mesenchymal transition effects of N ‐acetyl‐seryl‐aspartyl‐lysyl‐proline

67. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2

68. CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology

69. NAD

70. Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease

71. Dietary Magnesium Insufficiency Induces Salt-Sensitive Hypertension in Mice Associated With Reduced Kidney Catechol-O-Methyl Transferase Activity

72. Anterior pituitary function in Rathke's cleft cysts versus nonfunctioning pituitary adenomas

73. Effect of Methionine Restriction on Aging: Its Relationship to Oxidative Stress

74. Development of the hyolaryngeal architecture in horseshoe bats: insights into the evolution of the pulse generation for laryngeal echolocation

75. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys

76. The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation

77. Supplementation with Red Wine Extract Increases Insulin Sensitivity and Peripheral Blood Mononuclear Sirt1 Expression in Nondiabetic Humans

78. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)

79. Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling

80. Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity

81. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules

82. Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways

83. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD

84. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs

85. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy

86. Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling

87. Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity

89. Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells

90. Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease

91. A ketogenic amino acid rich diet benefits mitochondrial homeostasis by altering the AKT/4EBP1 and autophagy signaling pathways in the gastrocnemius and soleus

92. Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiency

93. A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity

94. Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats

95. Proposal of classification of 'chronic kidney disease (CKD) with diabetes' in clinical setting

96. Sirtuins and Renal Oxidative Stress

97. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance

98. Cyclic and intermittent very low-protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty (fa/fa ) rats, an animal model of type 2 diabetes and obesity

99. Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice

100. PDGFRβ Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity

Catalog

Books, media, physical & digital resources